FHC
RPRX icon

First Horizon Corporation’s Royalty Pharma RPRX Stock Holding History

First Horizon Corporation’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$673 Sell
12
-455
-97% -$23.7K ﹤0.01% 1450
2026
Q1 		$22.4K Buy
467
+455
+3,792% +$19.9K ﹤0.01% 861
2025
Q4 		$464 Hold
12
– – ﹤0.01% 1423
2025
Q3 		$423 Buy
+12
New +$434 ﹤0.01% 1372

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

First Horizon Corporation's RPRX Position: Q2 2026 in Review

First Horizon Corporation reduced its Royalty Pharma (RPRX) stake by 97% in Q2 2026, selling an estimated $23.7K and leaving 12 shares worth $673. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

First Horizon Corporation first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $22.4K in Q1 2026. 183 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • First Horizon Corporation held 12 shares of Royalty Pharma worth $673 as of Q2 2026.
  • First Horizon Corporation sold 455 Royalty Pharma shares in Q2 2026, an estimated $23.7K.
  • Royalty Pharma made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1450 holding.
  • First Horizon Corporation first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Royalty Pharma position peaked at $22.4K in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.